J.P. Morgan Life Sciences Private Capital
Overview
J.P. Morgan Life Sciences Private Capital is a venture capital and growth equity investment team within J.P. Morgan Private Capital that invests in early and growth-stage healthcare companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pathalys Pharma | Aug 2024 | Series B | Co-investor |
| ABK Biomedical | Oct 2025 | Series D | Lead |
| GT Metabolic Solutions | Oct 2026 | Series C | Lead |
| Ottimo Pharma | Dec 2024 | Series A | Co-investor |
| Averna Therapeutics | Jun 2024 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is J.P. Morgan Life Sciences Private Capital based?
J.P. Morgan Life Sciences Private Capital is headquartered in New York City, New York, United States.
When was J.P. Morgan Life Sciences Private Capital founded?
J.P. Morgan Life Sciences Private Capital was founded in 2022.
How many portfolio companies does J.P. Morgan Life Sciences Private Capital have?
J.P. Morgan Life Sciences Private Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in J.P. Morgan Life Sciences Private Capital's portfolio?
Portfolio companies visible on Caplight include Pathalys Pharma, ABK Biomedical, GT Metabolic Solutions, Ottimo Pharma, Averna Therapeutics.
What was J.P. Morgan Life Sciences Private Capital's most recent investment shown here?
J.P. Morgan Life Sciences Private Capital's most recent investment in this portfolio sample was in GT Metabolic Solutions in 2026.
What sectors does J.P. Morgan Life Sciences Private Capital focus on?
J.P. Morgan Life Sciences Private Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does J.P. Morgan Life Sciences Private Capital focus on?
J.P. Morgan Life Sciences Private Capital typically invests at the Early stage.
What is J.P. Morgan Life Sciences Private Capital's AUM?
J.P. Morgan Life Sciences Private Capital's assets under management are estimated at over $500.0M.